5 Best No-Fee DRIP Stocks to Buy Now

2. AbbVie Inc. (NYSE: ABBV)

Number of Hedge Fund Holders: 82
Dividend Yield: 4.38%

AbbVie Inc. (NYSE: ABBV), a US-based publicly traded biopharmaceutical and healthcare company, is next on our list of the best no-fee DRIP stocks to buy now. The company ranks 2nd and operates through its subsidiary companies as well, like AbbVie GK and Pharmacyclics.

Cowen analysts this August raised the price target on shares of AbbVie Inc. (NYSE: ABBV) from $120 to $130. Additionally, Argus analyst David Toung holds a Buy rating on the stock as well.

In the second quarter of 2021, AbbVie Inc. (NYSE: ABBV) had an EPS of $3.11, beating estimates by $0.08. The company’s revenue was $13.96 billion, up 33.9% year over year and beating estimates by $322.64 million. AbbVie Inc. (NYSE: ABBV) has gained 11.81% in the past 6 months and 12.72% year to date.

By the end of the second quarter of 2021, 82 hedge funds out of the 873 tracked by Insider Monkey held stakes in AbbVie Inc. (NYSE: ABBV) worth roughly $5.4 billion. This is compared to 72 hedge funds in the previous quarter with a total stake value of approximately $5.9 billion.